Trial site
Gansu Cancer Hospital
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Thyroid cancer3 trials
- Gastric and oesophageal cancer2 trials
- Neuroendocrine tumours2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Not yet recruiting4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Sun Yat-sen University2 trials
- Antengene Biologics Limited1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Recruiting
Recruiting
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients(Rocket Trial)
Recruiting
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026